Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Haspin Kinase
    (4)
  • Adenosine Receptor
    (1)
  • CDK
    (1)
  • DYRK
    (1)
  • IRAK
    (1)
  • Others
    (6)
Filter
Search Result
Results for "

haspin kinase

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | Inhibitors_Agonists
Haspin-IN-3
T605122416569-95-2
Haspin-IN-3 is a potent haspin inhibitor with an IC50 of 14 nM.Haspin-IN-3 has anticancer activity.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
MU1920
T204482
MU1920 is an ATP-competitive, selective inhibitor of haspin with an IC50 of 6 nM. In mouse plasma and microsomes, it demonstrates favorable pharmacokinetic properties and metabolic stability. Although it lacks significant anticancer activity, MU1920 is suitable for developing chemical probes.
  • Inquiry Price
Size
QTY
AZ1495
T143672196204-23-4
AZ1495 is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Which Shows activity in treatment of mutant MYD88L265P diffuse large B-cell lymphoma (DLBCL).
  • Inquiry Price
Size
QTY
LDN-192960
TQ0111184582-62-5
LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).
  • Inquiry Price
Size
QTY
LDN-192960 hydrochloride
T118302309172-48-1
LDN-192960 hydrochloride is an inhibitor of Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) and Haspin, with IC50 values of 48 nM and 10 nM, respectively.
  • Inquiry Price
1-2 weeks
Size
QTY
LDN-209929
LDN209929, LDN 209929, LDN-209929
T243961233355-57-1
LDN-209929 2HCl is a potent and selective inhibitor of haspin kinase.
  • Inquiry Price
6-8 weeks
Size
QTY
haspin-in-1
T60477
Haspin-IN-1 (compound 2a) is an inhibitor of haspin (haploid germ cell-specific nuclear protein kinase) with an IC50 of 119 nM. It also inhibits CLK1, DYRK1A, and CDK9 with IC50 values of 221 nM, 916.3 nM, and 406.8 nM, respectively. Haspin-IN-1 has potential for developing new anticancer drugs [1].
  • Inquiry Price
10-14 weeks
Size
QTY
LDN-209929 dihydrochloride
T620111784281-97-5
LDN-209929 dihydrochloride is a potent and selective inhibitor of haspin kinase (IC50= 55 nM), demonstrating 180-fold selectivity versus DYRK2 (IC50= 9.9 μM).
  • Inquiry Price
6-8 weeks
Size
QTY
MELK-8a
T624171922153-17-0
MELK-8a (NVS-MELK8a) is a potent and selective inhibitor of maternal embryonic leucine zipper kinase (MELK), with an IC50 of 2 nM and an IC50 of 0.42 μM in cellular assays. MELK is crucial in regulating mitosis in cancer cells.
  • Inquiry Price
1-2 weeks
Size
QTY
5-Iodotubercidin
5-ITu, NSC 113939
T674524386-93-4
5-Iodotubercidin (NSC-113939) is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
  • Inquiry Price
Size
QTY
CHR-6494 TFA
T95211458630-17-5
CHR-6494 TFA is a potent haspin inhibitor with an IC50 of 2 nM, inhibiting histone H3T3 phosphorylation. It induces apoptosis in cancer cells, including melanoma and breast cancer, and is useful for cancer research.
  • Inquiry Price
Size
QTY